Cicatricial pemphigoid of the oropharynx after allogeneic stem cell transplantation for relapsed follicular lymphoma

被引:7
作者
Aisa, Y
Mori, T
Nakazato, T
Yamazaki, R
Yamagami, J
Amagai, M
Ikeda, Y
Okamoto, S
机构
[1] Keio Univ, Sch Med, Dept Med, Div Hematol,Shinjuku Ku, Tokyo 1608582, Japan
[2] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan
关键词
autoimmune blistering disease; cicatricial pemphigoid; autoantibody; allogeneic stem cell transplantation; graft-versus-host disease;
D O I
10.1532/IJH97.05061
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 44-year-old woman with refractory follicular lymphoma underwent allogeneic stem cell transplantation (SCT) and achieved complete remission. Grade III acute graft-versus-host disease (GVHD) developed on day 23, but no chronic GVHD occurred. The patient developed severe erosion with bullous lesions in the oral cavity 18 months after SCT. At that time, the lymphoma remained in complete remission, and she had no clinical or laboratory findings suggesting chronic GVHD. A biopsy of the oral mucosa showed moderate lymphoplasmacytic infiltration and subepidermal bullae, and direct immunofluorescence staining demonstrated linear deposition of C3 at the dermo-epidermal junction. An immunoblotting assay using human epidermal extracts confirmed the presence in her serum of an antibody against the 230-kd bullous pemphigoid antigen I (BPAG1). A diagnosis of cicatricial pemphigoid (CP) was made, and complete resolution of the CP was achieved with prednisolone therapy. ne occurrence of autoimmune blistering diseases is rare after allogeneic SCT.
引用
收藏
页码:266 / 269
页数:4
相关论文
共 19 条
[1]  
BURGER J, 1992, BONE MARROW TRANSPL, V9, P139
[2]   The first international consensus on mucous membrane pemphigoid - Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators [J].
Chan, LS ;
Ahmed, AR ;
Anhalt, GJ ;
Bernauer, W ;
Cooper, KD ;
Elder, MJ ;
Fine, JD ;
Foster, S ;
Ghohestani, R ;
Hashimoto, T ;
Hoang-Xuan, T ;
Kirtschig, G ;
Korman, NJ ;
Lightman, S ;
Lozado-Nur, F ;
Marinkovich, MP ;
Mondino, BJ ;
Prost-Squarcioni, C ;
Rogers, RS ;
Setterfield, JF ;
West, DP ;
Wojnarowska, F ;
Woodley, DT ;
Yancey, KB ;
Zillikens, D ;
Zone, JJ .
ARCHIVES OF DERMATOLOGY, 2002, 138 (03) :370-379
[3]  
DELBALDO C, 1992, BONE MARROW TRANSPL, V10, P377
[4]   Successful anti-CD20 antibody treatment of pemphigus foliaceus after unrelated cord blood transplantation [J].
Herr, AL ;
Hatami, A ;
Kokta, V ;
Dalle, JH ;
Champagne, MA ;
Duval, M .
BONE MARROW TRANSPLANTATION, 2005, 35 (04) :427-428
[5]   IMMUNE-MECHANISMS IN CYCLOSPORINE-INDUCED SYNGENEIC GRAFT-VERSUS-HOST DISEASE [J].
HESS, AD ;
FISCHER, AC .
TRANSPLANTATION, 1989, 48 (06) :895-900
[6]   DEVELOPMENT OF PEMPHIGUS-VULGARIS-LIKE LESIONS IN SEVERE COMBINED IMMUNODEFICIENCY DISEASE MICE RECONSTITUTED WITH LYMPHOCYTES FROM PATIENTS [J].
JUHASZ, I ;
LAZARUS, GS ;
MURPHY, GF ;
SHIH, IM ;
HERLYN, M .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (05) :2401-2407
[7]  
Kamisato T, 1997, AM J GASTROENTEROL, V92, P1238
[8]  
Kikuchi A, 1999, ARCH DERMATOL, V135, P82
[9]  
LACOUR JP, 1988, PRESSE MED, V17, P1367
[10]  
LISTER J, 1987, J CLIN LAB IMMUNOL, V24, P19